비교리스트

 카트 문의
시장보고서
상품코드
1595024

세계의 스캐폴드 기술 시장

Scaffold Technology
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 89 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 스캐폴드 기술 시장은 2030년까지 28억 달러에 달할 전망

2023년에 18억 달러로 추정되는 세계의 스캐폴드 기술 시장은 분석 기간인 2023-2030년에 CAGR 7.0%로 성장하며, 2030년에는 28억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 하이드로겔은 CAGR 7.5%를 기록하며, 분석 기간 종료시에는 13억 달러에 달할 것으로 예측됩니다. 폴리메릭 스캐폴드(Polymeric Scaffolds) 분야의 성장률은 분석 기간 중 CAGR 6.0%로 추정됩니다.

미국 시장은 추정 4억 8,090만 달러, 중국은 CAGR 6.5%로 성장 예측

미국의 스캐폴드 기술 시장은 2023년에 4억 8,090만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2023-2030년 CAGR을 6.5%로서 2030년까지 4억 3,550만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 6.6%와 5.6%로 예측됩니다. 유럽에서는 독일이 CAGR 5.7%로 성장할 것으로 예측됩니다.

세계의 스캐폴드 기술 시장 - 주요 동향과 촉진요인 정리

스캐폴드 기술은 재생의료의 뉴프론티어를 어떻게 개척하고 있는가?

스캐폴드 기술은 재생의료의 최전선에 있으며, 손상되거나 병든 조직을 복구하는 데 있으며, 세포 증식과 조직 형성을 위한 중요한 프레임워크를 제공합니다. 이 기술은 생체적합성 물질을 사용하여 체내에서 새로운 세포의 성장을 지원하는 스캐폴딩 역할을 하는 3D 구조물을 생성합니다. 이 스캐폴더는 세포외 매트릭스를 모방하여 세포의 접착, 증식 및 새로운 조직 형성을 촉진합니다. 조직공학, 약물전달, 줄기세포 연구 등에 광범위하게 적용되어 장기 부족에 대응하고, 상처 치유를 촉진하며, 복잡한 질병에 대한 보다 효과적인 치료 옵션을 창출할 수 있을 것으로 기대되고 있습니다.

스캐폴드 기술 시장의 주요 부문은?

주요 재료에는 천연, 합성, 복합 비계가 있으며, 각 재료는 특정 용도에 따라 고유한 이점을 제공합니다. 콜라겐이나 키토산과 같은 천연 비계는 생체 적합성이 장점이지만, 합성 비계와 같은 구조적 강도가 부족할 수 있습니다. 폴리유산(PLA)이나 폴리에틸렌글리콜(PEG)과 같은 합성 소재는 견고한 구조적 지지력을 제공합니다. 한편, 복합 비계는 천연 및 합성 요소를 결합하여 생체 적합성과 강도의 균형을 제공합니다. KEYWORD의 용도는 조직 공학 및 재생 의학에서 약물전달 시스템 및 줄기세포 연구에 이르기까지 다양합니다. 최종사용자에는 병원, 연구기관, 바이오 제약회사 등이 포함되며, 재생의료와 조직공학에 중점을 둔 연구기관이 큰 비중을 차지합니다. 바이오 제약사들은 3D 스캐폴드가 기존 2D 세포배양보다 더 정확한 인체 조직 모델을 제공하므로 의약품 시험 및 개발에 스캐폴드 기술을 채택하는 사례가 늘고 있습니다. 또한 병원이나 전문 클리닉에서도 특히 상처 치료나 재건 수술과 같은 임상 현장에서 스캐폴드가 사용되기 시작했습니다.

스캐폴드 기술은 의료 분야에서 어떻게 적용되고 있는가?

조직공학에서 스캐폴딩 기술은 특히 뼈, 연골, 피부와 같은 손상된 조직을 대체하고 복구하는 구조물을 만드는 데 사용됩니다. 비계는 또한 재생의학에서 줄기세포의 성장을 지원하는 데 사용되어 퇴행성 질환 및 장기 수복에 대한 치료 가능성을 제공합니다. 또한 약물전달에서 비계는 치료제의 제어된 방출을 가능하게 하여 약효를 향상시키고 부작용을 줄일 수 있습니다. 임상 장면에서는 상처 치유에 적용되어 피부 조직 재생을 촉진하고 화상 환자 및 만성 상처 환자의 예후를 개선할 수 있습니다.

스캐폴드 기술 시장의 성장을 가속하는 요인은 무엇인가?

스캐폴드 기술 시장의 성장은 생체 재료의 발전, 재생 의학 연구 증가, 장기 및 조직 복구 솔루션에 대한 수요 증가, 3D 프린팅 및 나노테크놀러지의 혁신으로 스캐폴드 기술의 적용 범위가 확대되어 복잡한 맞춤형 비계 제조가 가능해졌습니다. 가능케 했습니다. 장기 이식에 대한 대체 치료법 개발, 조직 재생 촉진, 약물전달 강화에 대한 관심이 높아지면서 스캐폴드 기술이 이러한 목표에 필수적인 지원을 제공함에 따라 수요가 더욱 증가하고 있습니다. 또한 재생 의학 연구에 대한 자금 지원 증가, 생명공학 기업간의 제휴, 임상 적용의 저변 확대가 시장 성장에 기여하며 스캐폴딩 기술의 폭넓은 채택을 지원하고 있습니다.

부문

유형(하이드로겔, 고분자 스캐폴드, 마이크로 패턴 표면 마이크로플레이트, 나노섬유 기반 스캐폴드), 용도(줄기세포 치료, 재생의료, 조직공학, Drug Discovery, 기타 용도), 최종 용도(바이오테크놀러지·제약 기업, 연구소·연구소, 병원·진단 센터, 기타 최종 용도)

조사 대상 기업의 예(총 34건)

  • 3D Biotek LLC
  • Avacta Life Sciences Limited
  • Becton
  • Corning Inc.
  • Dickinson and Company
  • Marticel GmbH
  • Merck and Company
  • Molecular Matrix Inc.
  • Nanofiber Solutions
  • NuVasive, Inc.
  • Pelo Biotech GmbH
  • ReproCELL Europe Ltd.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 24.11.27

Global Scaffold Technology Market to Reach US$2.8 Billion by 2030

The global market for Scaffold Technology estimated at US$1.8 Billion in the year 2023, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Hydrogels, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Polymeric Scaffolds segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$480.9 Million While China is Forecast to Grow at 6.5% CAGR

The Scaffold Technology market in the U.S. is estimated at US$480.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$435.5 Million by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Scaffold Technology Market - Key Trends and Drivers Summarized

How Is Scaffold Technology Pioneering New Frontiers in Regenerative Medicine?

Scaffold technology is at the forefront of regenerative medicine, providing a crucial framework for cell growth and tissue formation in the repair of damaged or diseased tissues. This technology uses biocompatible materials to create 3D structures that act as scaffolds, supporting the growth of new cells in the body. These scaffolds mimic the extracellular matrix, encouraging cells to adhere, proliferate, and form new tissue. Scaffold technology is widely applied in tissue engineering, drug delivery, and stem cell research, as it holds promise for addressing organ shortages, enhancing wound healing, and creating more effective therapeutic options for complex diseases.

What Are the Key Segments in the Scaffold Technology Market?

Key materials include natural, synthetic, and composite scaffolds, each offering unique benefits for specific applications. Natural scaffolds, derived from sources like collagen and chitosan, are favored for their biocompatibility but may lack the structural strength found in synthetic scaffolds. Synthetic materials, such as polylactic acid (PLA) and polyethylene glycol (PEG), provide robust structural support, while composite scaffolds combine both natural and synthetic elements, offering a balance of biocompatibility and strength. Applications of scaffold technology range from tissue engineering and regenerative medicine to drug delivery systems and stem cell research. End-users include hospitals, research institutions, and biopharmaceutical companies, with research institutions holding a significant share due to their focus on regenerative medicine and tissue engineering. Biopharmaceutical companies are increasingly adopting scaffold technology for drug testing and development, as 3D scaffolds provide a more accurate model of human tissue than traditional 2D cell cultures. Hospitals and specialized clinics are also beginning to use scaffolds in clinical settings, particularly for wound care and reconstructive surgeries.

How Is Scaffold Technology Applied Across Medical Fields?

In tissue engineering, scaffold technology is used to create constructs that can replace or repair damaged tissues, particularly in cases of bone, cartilage, and skin injuries. Scaffolds are also used in regenerative medicine to support stem cell growth, offering potential treatments for degenerative diseases and organ repair. Additionally, in drug delivery, scaffolds allow for the controlled release of therapeutic agents, improving drug efficacy and reducing side effects. In clinical settings, scaffold technology is applied in wound healing, where it accelerates the regeneration of skin tissue and improves outcomes for burn victims and chronic wound patients.

What Factors Are Driving the Growth in the Scaffold Technology Market?

The growth in the Scaffold Technology market is driven by several factors, including advancements in biomaterials, increased research in regenerative medicine, and a growing demand for organ and tissue repair solutions. Innovations in 3D printing and nanotechnology have expanded the applications of scaffold technology, enabling the production of complex and customized scaffolds. The focus on developing alternative treatments for organ transplants, accelerating tissue regeneration, and enhancing drug delivery has further fueled demand, as scaffold technology provides essential support for these goals. Additionally, increased funding for regenerative medicine research, partnerships between biotech companies, and an expanding base of clinical applications have contributed to market growth, supporting the broader adoption of scaffold technology.

SCOPE OF STUDY:

The report analyzes the Scaffold Technology market in terms of US$ Thousand by the following Application; End-Use; Type, and Geographic Regions/Countries:

Segments:

Type (Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds); Application (Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery, Other Applications); End-Use (Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • 3D Biotek LLC
  • Avacta Life Sciences Limited
  • Becton
  • Corning Inc.
  • Dickinson and Company
  • Marticel GmbH
  • Merck and Company
  • Molecular Matrix Inc.
  • Nanofiber Solutions
  • NuVasive, Inc.
  • Pelo Biotech GmbH
  • ReproCELL Europe Ltd.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Scaffold Technology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Tissue Engineering Propel Scaffold Technology Adoption
    • Rising Demand for 3D-Printed Scaffolds Expands Market Opportunities
    • Increasing Focus on Regenerative Medicine Spurs Growth
    • Improved Biocompatibility in Scaffold Materials Strengthens Business Case
    • Expansion of Scaffold Applications in Drug Discovery Drives Market
    • Emerging Use of Nanotechnology in Scaffold Design Expands Opportunities
    • Advances in Bioengineering Techniques Drive Scaffold Market Growth
    • Increasing Investments in Healthcare R&D Strengthen Market Potential
    • Rising Popularity of Organ Regeneration Supports Scaffold Development
    • Increased Use of Biodegradable Scaffolds Expands Addressable Market
    • Rising Incidence of Chronic Diseases Drives Demand for Scaffolding Technology
    • Development of Novel Biomaterials for Scaffolds Enhances Market Potential
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Scaffold Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Scaffold Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Hydrogels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Hydrogels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polymeric Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Polymeric Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Micropatterned Surface Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Micropatterned Surface Microplates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Nanofiber Based Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Nanofiber Based Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World 7-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 16: World 7-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 19: World Scaffold Technology Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World 7-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 25: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: USA 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: USA 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Canada 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Canada 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • JAPAN
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Japan 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Japan 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • CHINA
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: China 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: China 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • EUROPE
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Scaffold Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for Scaffold Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Europe 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • FRANCE
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: France 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • GERMANY
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Germany 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: Italy 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • UNITED KINGDOM
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: UK 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of World 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 97: Rest of World 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제